You are here

Publications

Angiochem's technology and products have been well reported in scientific literature and at scientific meetings. Access those articles, posters, and presentations via the links below.

You will need Adobe Acrobat Reader to view these files. A free download is available here >

Peer-Reviewed Publications

Angiochem Publications

Demeule M et al. Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties

Drappazt et al. Phase I Study of GRN1005 in Recurrent Malignant Glioma

Kurzrock, R. et al. Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors. Molecular Cancer Therapeutics, 12/2/2011.

Bertrand, Y, et.al, Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1, British Journal of Cancer (2011) 105, 1697 – 1707

Demeule M, et al. Involvement of the low-density lipoprotein receptorrelated protein in the transcytosis of the brain delivery vector Angiopep-2. J Neurochem 2008 10.1111/j.1471-4159.2008.05492.x

Demeule M, et al. Identification and Design of Peptides as a New Drug Delivery System for the Brain, JPET 324:1064-1072, 2008.

Turcotte S, et al. Roles of the Multidrug Resistance Transporter PGlycoprotein. From: Blood Brain Barriers - From ontogeny to artificial interfaces, Dermeitzel R, Spray DS, Nedergaard M, eds. 2006.

Demeule M, et al. Brain Endothelial Cells as Pharmacological Targets in Brain Tumors. Mol Neurobiol 30:157-183, 2004.

Demeule M, et al. Drug transport to the brain: Key roles for the efflux pump P-glycoprotein in the blood-brain barrier. Vasc Pharmacol 38:339-348, 2002.

Regina A, et al. Multidrug resistance in brain tumors: Roles of the blood-brain barrier. Cancer and Metastasis Reviews 20:13-25, 2001.

Regina A, et al. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol 2008, 1-13.

Thomas FC. Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer. Pharm Res 2009 26(11): 2486-94

Che C, et al. New Angiopep-Modified Doxorubicin (ANG1007) and Etoposide (ANG1009) Chemotherapeutics With Increased Brain Penetration. J Med Chem, 2010, 53 (7), 2814-2824.

External Academic Group

Angiopep-2-conjugated liposomes encapsulating c-secretase inhibitor for targeting glioblastoma stem cells

Synthesis of a ‘‘clickable’’ Angiopep-conjugated p-coumaric acid for brain-targeted delivery

Angiopep-2-Mediated Delivery of Human Manganese Superoxide Dismutase in Brain Endothelial Cells and its Protective Effect Against Oxidative Stress

Fluorescent Carbonaceous Nanodots for Noninvasive Glioma Imaging after Angiopep?2 Decoration

Angiopep-Conjugated Electro-Responsive Hydrogel Nanoparticles: Therapeutic Potential for Epilepsy

A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein

Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma

Two-Order Targeted Brain Tumor Imaging By Using An Optical/ Paramagnetic Nanoprobe across the Blood Brain Barrier

Retro-Inverso Isomer of Angiopep-2: A Stable D?Peptide Ligand Inspires Brain-Targeted Drug Delivery

Angiopep?2 and Activatable Cell-Penetrating Peptide Dual- Functionalized Nanoparticles for Systemic Glioma-Targeting Delivery

Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating

Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas

Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles

Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome

Angiopep-conjugated poly(ethylene glycol)-co-poly(e-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma

Publications on the Blood-Brain Barrier

Jones AR, Shusta EV. Blood-Brain Barrier Transport of Therapeutics via Receptor-Mediation. Pharm Res. 2007 September; 24(9): 1759-1.

Begley DJ. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacology & Therapeutics 104 (2004) 29-45.

Schinkel AH. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Advanced Drug Delivery Reviews 36 (1999) 179-194.

Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiology of Disease 37 (2010) 48–57.

Deeken JF, Loscher W. The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses. Clin Cancer Res 2007;13(6) 1663-1674.

Posters and Presentations

Society of Neuroscience Meeting 2014

AACR congress 2014

San Antonio Breast Cancer Symposium 2013

AACR-NCI-EORTC Congress 2013

TIDES Meeting 2013

Neuroscience 2012, October 13-17, 2010, New Orleans, LA, USA

AACR/NCI/EORTC Annual Meeting, November 15, 2011, SF, CA

Neurosciences 2010, November 13-17, 2010, San Diego, CA, USA.

EORTC-NCI-AACR Annual Meeting 2009, Boston, MA, November 15-19, 2009

Society for Neuroscience Annual Meeting, Chicago, IL, USA, 17/21-Oct-2009

American Association for Cancer Research (AACR) 100th annual meeting, Denver, Colorado, USA, 18/22-Apr-2009

International Brain Barriers/Neuroscience Meeting, Gleneden Beach, Oregon, USA, 19/21-Mar-2009.

SOT 48th Annual Meeting, Baltimore, USA, 15/19 Mar-2009 (for SOT posters)

Society for Neuro-Oncology Annual Meeting, Las Vegas, Nevada, USA, 21/22-Nov-2008

Neuroscience 2008, Washington DC, USA, 18-Nov-2008

EORTC-NCI-AACR Annual Meeting 2008, Geneva, Switzerland, October 22/23, 2008